CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 69, Issue 1, Pages 103-114
Publisher
Springer Science and Business Media LLC
Online
2019-12-16
DOI
10.1007/s00262-019-02444-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Truncated CD200 stimulates tumor immunity leading to fewer lung metastases in a novel Wistar rat metastasis model
- (2018) Jun Kuwabara et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CD200fc enhances anti-tumoral immune response and inhibits visceral metastasis of breast carcinoma
- (2018) Nuray Erin et al. Oncotarget
- Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced Colitis
- (2016) Zhiqi Chen et al. PLoS One
- CD200 Inhibits Inflammatory Response by Promoting KATP Channel Opening in Microglia Cells in Parkinson’s Disease
- (2016) Yi Ren et al. MEDICAL SCIENCE MONITOR
- Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response
- (2014) N Erin et al. ONCOGENE
- Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival
- (2014) Aaron Prodeus et al. Molecular Therapy-Nucleic Acids
- Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma
- (2013) Nuray Erin et al. BREAST CANCER RESEARCH AND TREATMENT
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors
- (2013) E. Gilboa et al. CLINICAL CANCER RESEARCH
- Premetastatic soil and prevention of breast cancer brain metastasis
- (2013) Y. Liu et al. NEURO-ONCOLOGY
- Up-regulated ATP-sensitive potassium channels play a role in increased inflammation and plaque vulnerability in macrophages
- (2012) Ming-Ying Ling et al. ATHEROSCLEROSIS
- PEGylation and Biodistribution of an anti-MUC1 Aptamer in MCF-7 Tumor-Bearing Mice
- (2012) Chiara Da Pieve et al. BIOCONJUGATE CHEMISTRY
- CD4+CD8+ T Cells Represent a Significant Portion of the Anti-HIV T Cell Response to Acute HIV Infection
- (2012) M. A. Frahm et al. JOURNAL OF IMMUNOLOGY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- Immunological effects of Taxol and Adryamicin in breast cancer patients
- (2011) C. Panis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype
- (2010) Gianluca Storci et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas
- (2010) Juliette Desfrançois et al. PLoS One
- Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
- (2010) Abhik Bandyopadhyay et al. PLoS One
- Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice
- (2009) Reginald M. Gorczynski et al. BREAST CANCER RESEARCH AND TREATMENT
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
- (2009) Dimitrios Iliopoulos et al. CELL
- Increased frequency of nonconventional double positive CD4CD8 αβ T cells in human breast pleural effusions
- (2009) Juliette Desfrançois et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of a CD200 Transgene Is Necessary for Induction but Not Maintenance of Tolerance to Cardiac and Skin Allografts
- (2009) R. M. Gorczynski et al. JOURNAL OF IMMUNOLOGY
- A Comparison of the Biological Properties of Small Molecular Weight Agonists and Antagonists of CD200:CD200R Interactions
- (2008) Reg Gorczynski et al. Medicinal Chemistry
- Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters Substance P level
- (2008) Nuray Erin et al. REGULATORY PEPTIDES
- Peptides of CD200 Modulate LPS-Induced TNF-α Induction and Mortality In Vivo
- (2007) Reg Gorczynski et al. JOURNAL OF SURGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More